_PRIVATE_LIMITED.webp)
Cyone Med Solutions (Opc) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.68 Cr
- Revenue Growth 33.62%
- Profit Growth -131.72%
- Ebitda -131.29%
- Net Worth -127.43%
- Total Assets -2.42%
About Cyone Med Solutions (Opc)
Cyone Med Solutions (Opc) Private Limited (CMSOPL) is a registered startup operating as a Company incorporated in India on 16 August 2017 (Seven years and five months 29 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.68 Cr.
Tatineni Srikanth serves as a director at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U72900TG2017OPC118896
-
Company No.
118896
-
Incorporation Date
16 Aug 2017
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Cyone Med Solutions (Opc)?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tatineni Srikanth
|
Director | 16-Aug-2017 | Current |
Financial Performance of Cyone Med Solutions (Opc).
Cyone Med Solutions (Opc) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 33.62% increase. The company also saw a substantial fall in profitability, with a 131.72% decrease in profit. The company's net worth observed a substantial decline by a decrease of 127.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cyone Med Solutions (Opc)?
In 2022, Cyone Med Solutions (Opc) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Clawins Exims Private LimitedTatineni Srikanth is a mutual person
Charges (Loans)
₹16.80 M
₹0
Charges Breakdown by Lending Institutions
- Uco Bank : 1.68 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 May 2024 | Uco Bank | ₹1.68 Cr | Open |
How Many Employees Work at Cyone Med Solutions (Opc)?
Unlock and access historical data on people associated with Cyone Med Solutions (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cyone Med Solutions (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cyone Med Solutions (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
